Elsevier Inc.

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Hsu
    Hsu
  3. Kris
    Kris
  4. Berger
    Berger
  5. Giralt
    Giralt
  6. Perales
    Perales
  7. Riely
    Riely
  8. Hanash
    Hanash
  9. Peled
    Peled
  10. Solit
    Solit

Groups

  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)
  7. Center for Hematologic Malignancies (166)
  8. Hematologic Malignancies, Division of (151)
  9. Sloan Kettering Institute Postdocs (125)
  10. Bone Marrow Transplant (116)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (205)
  2. Meeting Abstract (182)
  3. Review (14)
  4. Book Section (9)
  5. Editorial (8)
  6. Conference Paper (1)
  7. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)

More Groups

People
  1. Marc Ladanyi (97)
  2. Marcel Van Den Brink (61)
  3. Katharine Hsu (52)
  4. Mark Kris (44)
  5. Michael Berger (38)
  6. Miguel-Angel Perales (37)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (26)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (100)
  2. Journal of Thoracic Oncology (89)
  3. Urologic Oncology: Seminars and Original Investigations (31)
  4. European Journal of Cancer (30)
  5. International Journal of Radiation Oncology, Biology, Physics (18)
  6. Transplantation and Cellular Therapy (13)

More Publications

Results (420)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stakeholders' perceptions and information needs regarding research medical donation
    Journal Article

    Epstein, A. S.; Hamilton, J. G.; Shuk, E.; Romano, D. R.; Lynch, K.; Khan, E.; Genoff, M.; Michael, C.; Iacobuzio-Donahue, C.
    Journal of Pain and Symptom Management (2019)

    Fulltext@MSK | Save
  • Chromophobe renal cell carcinoma: Results from a large single-institution series
    Journal Article

    Casuscelli, J.; Becerra, M. F.; Seier, K.; Manley, B. J.; Benfante, N.; Redzematovic, A.; Stief, C. G.; Hsieh, J. J.; Tickoo, S. K.; Reuter, V. E.; more...
    Clinical Genitourinary Cancer (2019)

    Fulltext@MSK | Save
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2
    Journal Article

    Zhu, B.; Cao, A.; Li, J.; Young, J.; Wong, J.; Ashraf, S.; Bierzynska, A.; Menon, M. C.; Hou, S.; Sawyers, C.; more...
    Kidney International (2019)

    Fulltext@MSK | Save
  • Mucinous tubular and spindle-cell carcinoma of the kidney: Clinical features, genomic profiles, and treatment outcomes
    Journal Article

    Ged, Y.; Chen, Y. B.; Knezevic, A.; Donoghue, M. T. A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Hakimi, A. A.; Russo, P.; more...
    Clinical Genitourinary Cancer (2019)

    Fulltext@MSK | Save
  • JAK2, PD-L1, and PD-L2 (9p24.1) amplification in metastatic mucosal and cutaneous melanomas with durable response to immunotherapy
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias Stella, J. A. 3rd; Chang, J. C.; Chen, Y.; Tang, L. H.; DeLair, D. F.; Yao, J.; Ladanyi, M.; more...
    Human Pathology (2019)

    Fulltext@MSK | Save
  • Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology
    Editorial

    Salgado, R.; Solit, D. B.; Rimm, D. L.; Bogaerts, J.; Canetta, R.; Lively, T.; Lyerly, K.; Span, P. N.; Bateman-House, A.; Makady, A.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Metastatic chromophobe renal cell carcinoma: Presence or absence of sarcomatoid differentiation determines clinical course and treatment outcomes
    Journal Article

    Ged, Y.; Chen, Y. B.; Knezevic, A.; Casuscelli, J.; Redzematovic, A.; DiNatale, R. G.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; more...
    Clinical Genitourinary Cancer (2019)

    Fulltext@MSK | Save
  • Impact of high-molecular-risk mutations on transplantation outcomes in patients with myelofibrosis
    Journal Article

    Tamari, R.; Rapaport, F.; Zhang, N.; McNamara, C.; Kuykendall, A.; Sallman, D. A.; Komrokji, R.; Arruda, A.; Najfeld, V.; Sandy, L.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement
    Journal Article

    Dogan, S.; Ng, C. K. Y.; Xu, B.; Kumar, R.; Wang, L.; Edelweiss, M.; Scott, S. N.; Zehir, A.; Drilon, A.; Morris, L. G. T.; more...
    Human Pathology (2019)

    Fulltext@MSK | Save